{"id":"bromindione","rwe":[{"pmid":"4963164","year":"1967","title":"Further studies of bromindione, a newer anticoagulant.","finding":"","journal":"Current therapeutic research, clinical and experimental","studyType":"Clinical Study"},{"pmid":"13913300","year":"1962","title":"Study of bromindione, a new anticoagulant.","finding":"","journal":"JAMA","studyType":"Clinical Study"},{"pmid":"13749480","year":"1961","title":"p-Bromindione: a new, potent, long-acting oral anticoagulant drug.","finding":"","journal":"JAMA","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"fluidane","offLabel":[],"synonyms":["bromindione","bromophendione","bromophenindione","fluidane","haldinone"],"timeline":[],"brandName":"Fluidane","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells have locks on them, and the key to unlocking a specific lock is a molecule that fits perfectly. Fluidane is like a custom-made key that fits a specific lock, allowing it to turn and produce a desired effect. This process can help to regulate various bodily functions and treat different diseases.","oneSentence":"Fluidane works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Fluidane is a small molecule that binds to a specific protein target, modulating its activity and leading to a therapeutic response. The exact mechanism of action is unknown, but it is believed to involve the inhibition or activation of a specific signaling pathway."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3037","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BROMINDIONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:03:39.560902","biosimilars":[],"competitors":[],"genericName":"bromindione","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"OQZ7BND2QN","CHEBI":"CHEBI:135274","INN_ID":"1242","UMLSCUI":"C0054098","ChEMBL_ID":"CHEMBL288496","KEGG_DRUG":"D03164","PUBCHEM_CID":"14369","SNOMEDCT_US":"88352008","MESH_SUPPLEMENTAL_RECORD_UI":"C010689"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1967 Jul","pmid":"4963164","title":"Further studies of bromindione, a newer anticoagulant.","journal":"Current therapeutic research, clinical and experimental"},{"date":"1962 Jan 13","pmid":"13913300","title":"Study of bromindione, a new anticoagulant.","journal":"JAMA"},{"date":"1961 Sep 9","pmid":"13749480","title":"p-Bromindione: a new, potent, long-acting oral anticoagulant drug.","journal":"JAMA"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fluidane (BROMINDIONE) is a small molecule modality with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a result, there is limited information available on its pharmacokinetic properties, such as half-life and bioavailability. Further research is needed to determine its potential therapeutic applications and safety profile. The lack of approved indications and generic manufacturers suggests that it may be a patented compound.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}